← Leaderboards
David G Kingston
Virginia Polytechnic Inst And St Univ
$12,925,812
Attributed
$14,268,778
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$14,268,778 · 4
By mechanism
U01$9,493,374 · 1
R01$4,627,136 · 2
U19$148,268 · 1
Top collaborators
- Maria Belen Cassera5 shared
- Michael Goetz3 shared
- Jason Anderson Clement2 shared
Most similar at Virginia Polytechnic Inst And St Univ
Same institution · by research overlap
- Maria Belen Cassera$4,454,225
- Michael Goetz$412,168
- Jason Anderson Clement$259,315
Others in their field
Top investigators on “Malaria”
- Lawrence Corey · Fred Hutchinson Cancer Center$227,738,417
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$227,738,417
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$82,291,297
- Stephen Lev Hoffman · Sanaria, Inc.$79,440,588
- Constance Ann Benson · University Of California, San Diego$65,790,143
- David Heimbrook · Leidos Biomedical Research, Inc.$61,561,099
Research focus
MalariaTrainingProgramsPlantsPharmacologic SubstanceInstitutesBiological FactorsVirginiaFractionationChemistryAnalogOncologyAntineoplasticsEndocrinologyImmunologyNeurologyTuberculosisBotanicalsBotanyFinancial CompensationAffectCancer Immunology ScienceForestFunding
Grant awards (33)
Discovery and Mechanism of Antimalarial Natural Products$383,854
R01 · FY2018 · AT · contact PI
Discovery and Mechanism of Antimalarial Natural Products$394,092
R01 · FY2017 · AT · contact PI
Discovery and Mechanism of Antimalarial Natural Products$401,212
R01 · FY2016 · AT · contact PI
Discovery and Mechanism of Antimalarial Natural Products$398,685
R01 · FY2015 · AT · contact PI
Discovery and Mechanism of Antimalarial Natural Products$436,606
R01 · FY2014 · AT · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$186,500
U01 · FY2013 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$574,810
U01 · FY2012 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$574,810
U01 · FY2011 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$314,510
U01 · FY2011 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$579,810
U01 · FY2010 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$600,655
U01 · FY2009 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$232,400
U01 · FY2009 · TW · contact PI
BIODIVERSITY CONSERVATION AND DRUG DISCOVERY IN MADAGASCAR$599,386
U01 · FY2008 · TW · contact PI
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS$310,162
R01 · FY2008 · CA · contact PI
BIODIVERSITY CONSERVATION & DRUG DISCOVERY IN MADAGASCAR$728,311
U01 · FY2007 · TW · contact PI
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS$307,144
R01 · FY2007 · CA · contact PI
BIODIVERSITY CONSERVATION & DRUG DISCOVERY IN MADAGASCAR$709,383
U01 · FY2006 · TW · contact PI
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS$307,157
R01 · FY2006 · CA · contact PI
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR$726,467
U01 · FY2005 · TW
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS$305,446
R01 · FY2005 · CA
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR$726,469
U01 · FY2004 · TW
STUDIES OF TUBULIN-INTERACTIVE ANTICANCER DRUGS$320,923
R01 · FY2004 · CA
BIODIVERSITY CONSERVATION &DRUG DISCOVERY IN MADAGASCAR$671,468
U01 · FY2003 · TW
STUDIES OF THE PACLITAXEL TUBULIN INTERACTION$264,651
R01 · FY2003 · CA
BIODIVERSITY UTILIZATION IN MADAGASCAR AND SURINAME$776,513
U01 · FY2002 · TW
STUDIES OF THE PACLITAXEL TUBULIN INTERACTION$264,693
R01 · FY2002 · CA
ISOLATION OF NOVEL MECHANISM-BASED ANTITUMOR AGENTS$0
U19 · FY2002 · CA
BIODIVERSITY UTILIZATION IN MADAGASCAR AND SURINAME$744,000
U01 · FY2001 · TW
STUDIES OF THE PACLITAXEL TUBULIN INTERACTION$264,553
R01 · FY2001 · CA
ISOLATION OF NOVEL MECHANISM-BASED ANTITUMOR AGENTS$0
U19 · FY2001 · CA
BIODIVERSITY UTILIZATION IN MADAGASCAR AND SURINAME$747,882
U01 · FY2000 · TW
STUDIES OF THE PACLITAXEL TUBULIN INTERACTION$267,958
R01 · FY2000 · CA
ISOLATION OF NOVEL MECHANISM-BASED ANTITUMOR AGENTS$148,268
U19 · FY2000 · CA